David Dukhan

482 total citations
17 papers, 339 citations indexed

About

David Dukhan is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, David Dukhan has authored 17 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Infectious Diseases and 9 papers in Epidemiology. Recurrent topics in David Dukhan's work include HIV/AIDS drug development and treatment (10 papers), Biochemical and Molecular Research (8 papers) and Hepatitis C virus research (6 papers). David Dukhan is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), Biochemical and Molecular Research (8 papers) and Hepatitis C virus research (6 papers). David Dukhan collaborates with scholars based in France, United States and Italy. David Dukhan's co-authors include Jean‐Louis Imbach, Gilles Gosselin, Claire Pierra, Jean‐Pierre Sommadossi, Edward G. Bridges, Martin L. Bryant, L Placidi, Bud C. Tennant, Abdesslem Faraj and Erika Cretton-Scott and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.

In The Last Decade

David Dukhan

17 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Dukhan France 8 185 153 140 134 88 17 339
Erika Cretton-Scott United States 8 207 1.1× 209 1.4× 234 1.7× 125 0.9× 46 0.5× 10 423
Abdesslem Faraj France 10 177 1.0× 129 0.8× 203 1.4× 188 1.4× 152 1.7× 19 443
Jeremy L. Clark United States 6 134 0.7× 170 1.1× 212 1.5× 148 1.1× 60 0.7× 9 343
Danuta Madej Canada 8 157 0.8× 69 0.5× 153 1.1× 202 1.5× 157 1.8× 10 414
Quanlai Song United Kingdom 14 79 0.4× 83 0.5× 181 1.3× 375 2.8× 208 2.4× 25 543
Kanda S. Ramasamy United States 13 66 0.4× 62 0.4× 102 0.7× 323 2.4× 152 1.7× 25 463
Carolina C. P. Costa Brazil 8 321 1.7× 284 1.9× 100 0.7× 135 1.0× 319 3.6× 11 720
Kirupa Shanmuganathan United States 8 166 0.9× 85 0.6× 236 1.7× 215 1.6× 149 1.7× 9 478
Sanjib Bera United States 9 61 0.3× 82 0.5× 165 1.2× 156 1.2× 114 1.3× 19 281
Kenny Simmen Belgium 7 96 0.5× 128 0.8× 99 0.7× 99 0.7× 121 1.4× 8 327

Countries citing papers authored by David Dukhan

Since Specialization
Citations

This map shows the geographic impact of David Dukhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Dukhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Dukhan more than expected).

Fields of papers citing papers by David Dukhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Dukhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Dukhan. The network helps show where David Dukhan may publish in the future.

Co-authorship network of co-authors of David Dukhan

This figure shows the co-authorship network connecting the top 25 collaborators of David Dukhan. A scholar is included among the top collaborators of David Dukhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Dukhan. David Dukhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Dousson, Cyril B., Christopher Chapron, David N. Standring, et al.. (2011). 815 IDENIX NS5A HCV REPLICATION INHIBITORS WITH LOW PICOMOLAR, PAN-GENOTYPIC IN VITRO ANTIVIRAL ACTIVITY. Journal of Hepatology. 54. S326–S327. 7 indexed citations
2.
Dukhan, David, et al.. (2009). Synthesis of the first example of a nucleoside analogue bearing a 5′-deoxy-β-d-allo-septanose as a seven-membered ring sugar moiety. Carbohydrate Research. 344(4). 448–453. 8 indexed citations
3.
Leroy, Frédéric, David Dukhan, Richard Storer, et al.. (2008). Synthesis and antiviral evaluation of 4-fluoropyrazole-3-carboxamide nucleoside derivatives. Nucleic Acids Symposium Series. 52(1). 617–618. 2 indexed citations
4.
Leroy, Frédéric, David Dukhan, Richard Storer, et al.. (2008). Synthesis and antiviral evaluation of 7-fluoro-7-deaza-2-aminopurine nucleoside derivatives. Nucleic Acids Symposium Series. 52(1). 595–596. 3 indexed citations
5.
Dukhan, David, Richard Storer, J P Sommadossi, et al.. (2008). Synthesis and antiviral evaluation of a seven-membered sugar ring nucleoside analog, 9-(5-deoxy- -D-allo-septanosyl)-adenine. Nucleic Acids Symposium Series. 52(1). 611–612. 4 indexed citations
6.
Damont, Annelaure, et al.. (2007). Synthesis of 1′-C-Fluoromethyladenosine. Nucleosides Nucleotides & Nucleic Acids. 26(10-12). 1431–1434. 7 indexed citations
7.
Dukhan, David, et al.. (2005). SYNTHESIS OF 2′-C-METHYL-4′-THIO RIBONUCLEOSIDES. Nucleosides Nucleotides & Nucleic Acids. 24(5-7). 577–580. 10 indexed citations
8.
Dukhan, David, Frédéric Leroy, Maxime Durka, et al.. (2005). SYNTHESIS OF 5-AZA-7-DEAZAGUANINE NUCLEOSIDE DERIVATIVES AS POTENTIAL ANTI-FLAVIVIRUS AGENTS. Nucleosides Nucleotides & Nucleic Acids. 24(5-7). 671–674. 15 indexed citations
9.
Pierra, Claire, S. Benzaria, David Dukhan, et al.. (2004). Synthesis, Physicochemical and Pharmacokinetic Studies of Potential Prodrugs of β-L-2′-Deoxycytidine, a Selective and Specific Anti-HBV Agent. Antiviral chemistry & chemotherapy. 15(5). 269–279. 3 indexed citations
10.
Dukhan, David, Claire Pierra, S. Benzaria, et al.. (2003). 4′-C-Methyl-β-D-ribofuranosyl Purine and Pyrimidine Nucleosides Revisited. Nucleosides Nucleotides & Nucleic Acids. 22(5-8). 707–709. 6 indexed citations
11.
Hernández-Santiago, Brenda I., L Placidi, Achraf Al Faraj, et al.. (2002). Pharmacology of β- l -Thymidine and β- l -2′-Deoxycytidine in HepG2 Cells and Primary Human Hepatocytes: Relevance to Chemotherapeutic Efficacy against Hepatitis B Virus. Antimicrobial Agents and Chemotherapy. 46(6). 1728–1733. 43 indexed citations
12.
Bryant, Martin L., Edward G. Bridges, L Placidi, et al.. (2001). ANTI-HBV SPECIFIC β-L-2′-DEOXYNUCLEOSIDES. Nucleosides Nucleotides & Nucleic Acids. 20(4-7). 597–607. 23 indexed citations
13.
Bryant, Martin L., Edward G. Bridges, L Placidi, et al.. (2001). Antiviral l -Nucleosides Specific for Hepatitis B Virus Infection. Antimicrobial Agents and Chemotherapy. 45(1). 229–235. 144 indexed citations
14.
15.
Franchetti, Palmarisa, Stefano Marchetti, Loredana Cappellacci, et al.. (2000). Synthesis, Conformational Analysis, and Biological Activity ofC-Thioribonucleosides Related to Tiazofurin. Journal of Medicinal Chemistry. 43(7). 1264–1270. 35 indexed citations
16.
Franchetti, Palmarisa, Stefano Marchetti, Loredana Cappellacci, et al.. (1999). Structure-Activity Relationships of Tiazofurin Analogs: Synthesis and Computational Studies of 4′-Thio Derivatives of Thiophenfurin and Furanfurin. Nucleosides and Nucleotides. 18(4-5). 679–680. 5 indexed citations
17.
Dukhan, David, Roland Marquet, Bernard Ehresmann, et al.. (1999). 4′-Thio-RNA: Synthesis, Base Pairing Properties and Interaction with Dimerization Initiation Site of HIV-1. Nucleosides and Nucleotides. 18(6-7). 1423–1424. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erika Cretton-Scott Breakdown of academic impact, for papers by Abdesslem Faraj Breakdown of academic impact, for papers by Jeremy L. Clark Breakdown of academic impact, for papers by Danuta Madej Breakdown of academic impact, for papers by Quanlai Song Breakdown of academic impact, for papers by Kanda S. Ramasamy Breakdown of academic impact, for papers by Carolina C. P. Costa Breakdown of academic impact, for papers by Kirupa Shanmuganathan Breakdown of academic impact, for papers by Sanjib Bera Breakdown of academic impact, for papers by Kenny Simmen
Rankless by CCL
2026